| Houry Arine Kahwajian-mock, MD | |
|
10120 S Eastern Ave #130, Henderson, NV 89052 | |
| (702) 487-6880 | |
| (702) 473-5455 |
| Full Name | Houry Arine Kahwajian-mock |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 10120 S Eastern Ave #130, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568719052 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renown Regional Medical Center | Reno, NV | Hospital |
| Renown South Meadows Medical Center | Reno, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkhill Rahimzadeh Ellero Garol Mortensen Raman And Assoc Pc | 8325407711 | 57 |
News Archive
Thrombocytopenia in the first 24 hours after birth is not linked to patent ductus arteriosus in low birthweight infants, research shows.
First-of-its-kind study finds that black cancer survivors on these plans are far more likely to struggle to afford health care and medicine than their white counterparts, while black and white cancer survivors on other types of plans are equally unlikely to face these challenges.
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.
Despite a potentially disruptive U.S. Supreme Court Decision expected this summer, California officials are moving forward with the creation of a new, online health insurance market. ... "There are many different scenarios," said David Panush, director of government relations for the California Health Benefit Exchange. "Rather than trying to crystal-ball what the court may or may not do, we've got our foot on the pedal and we're going full speed ahead."
› Verified 9 days ago
| Entity Name | Valley Anesthesiology Consultants-beckett-pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437326857 PECOS PAC ID: 6507925849 Enrollment ID: O20081031000516 |
News Archive
Thrombocytopenia in the first 24 hours after birth is not linked to patent ductus arteriosus in low birthweight infants, research shows.
First-of-its-kind study finds that black cancer survivors on these plans are far more likely to struggle to afford health care and medicine than their white counterparts, while black and white cancer survivors on other types of plans are equally unlikely to face these challenges.
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.
Despite a potentially disruptive U.S. Supreme Court Decision expected this summer, California officials are moving forward with the creation of a new, online health insurance market. ... "There are many different scenarios," said David Panush, director of government relations for the California Health Benefit Exchange. "Rather than trying to crystal-ball what the court may or may not do, we've got our foot on the pedal and we're going full speed ahead."
› Verified 9 days ago
| Entity Name | Parkhill Rahimzadeh Ellero Garol Mortensen Raman And Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962103325 PECOS PAC ID: 8325407711 Enrollment ID: O20230703001318 |
News Archive
Thrombocytopenia in the first 24 hours after birth is not linked to patent ductus arteriosus in low birthweight infants, research shows.
First-of-its-kind study finds that black cancer survivors on these plans are far more likely to struggle to afford health care and medicine than their white counterparts, while black and white cancer survivors on other types of plans are equally unlikely to face these challenges.
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.
Despite a potentially disruptive U.S. Supreme Court Decision expected this summer, California officials are moving forward with the creation of a new, online health insurance market. ... "There are many different scenarios," said David Panush, director of government relations for the California Health Benefit Exchange. "Rather than trying to crystal-ball what the court may or may not do, we've got our foot on the pedal and we're going full speed ahead."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Houry Arine Kahwajian-mock, MD Po Box 400310, Las Vegas, NV 89140 Ph: (310) 222-2700 | Houry Arine Kahwajian-mock, MD 10120 S Eastern Ave #130, Henderson, NV 89052 Ph: (702) 487-6880 |
News Archive
Thrombocytopenia in the first 24 hours after birth is not linked to patent ductus arteriosus in low birthweight infants, research shows.
First-of-its-kind study finds that black cancer survivors on these plans are far more likely to struggle to afford health care and medicine than their white counterparts, while black and white cancer survivors on other types of plans are equally unlikely to face these challenges.
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.
Despite a potentially disruptive U.S. Supreme Court Decision expected this summer, California officials are moving forward with the creation of a new, online health insurance market. ... "There are many different scenarios," said David Panush, director of government relations for the California Health Benefit Exchange. "Rather than trying to crystal-ball what the court may or may not do, we've got our foot on the pedal and we're going full speed ahead."
› Verified 9 days ago
Raman S Grewal, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 129 W Lake Mead Pkwy, B-18, Henderson, NV 89015 Phone: 702-564-4440 Fax: 702-558-1522 | |
Michael A Fortunato, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: Valley Anesthesiology Consultants, 10120 S. Eastern Ave., Suite 130, Henderson, NV 89052 Phone: 702-487-6510 Fax: 702-405-7960 | |
Samuel D Rosenthal, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10120 S Eastern Ave #130, Henderson, NV 89052 Phone: 702-487-6880 Fax: 702-473-5455 | |
Gabriel Garcia, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 129 W Lake Mead Pkwy, #b-18, Henderson, NV 89015 Phone: 702-564-4440 Fax: 702-558-1522 | |
Dr. Andrew Malek, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10120 S Eastern Ave, Henderson, NV 89052 Phone: 702-487-6880 | |
Daniel E Batlan, MD, MBA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1661 W Horizon Ridge Pkwy, Suite #270, Henderson, NV 89012 Phone: 702-838-8004 Fax: 702-838-5085 | |
Laura Santos Pavia, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10120 S Eastern Ave #130, Henderson, NV 89052 Phone: 702-487-6880 Fax: 702-473-5455 |